Citius Pharmaceuticals (CTXR) Short term Debt (2011 - 2013)

Citius Pharmaceuticals (CTXR) has reported Short term Debt for 3 consecutive years, with $3152.0 the latest figure, recorded in Q1 2013.

• For the quarter ending Q1 2013, Short term Debt rose 98.61% year-over-year to $3152.0; the trailing twelve-month figure through Mar 2013 stood at $3152.0 (up 98.61% YoY), and the FY2012 full-year result was $2287.0, up 224.86% from the prior year.
• Short term Debt grew to $3152.0 in Q1 2013 per CTXR's latest filing, from $2724.0 in the prior quarter.
• Across five years, Short term Debt topped out at $3152.0 in Q1 2013 and bottomed at $387.0 in Q2 2011.
• Historically, Short term Debt has averaged $1760.2 across 3 years, with a median of $1876.0 in 2012.
• The sharpest annual moves came in 2012 and 2013: Short term Debt surged 459.43% in 2012, then soared 98.61% in 2013.
• Over 3 years, Short term Debt stood at $1076.0 in 2011, then soared by 153.16% to $2724.0 in 2012, then gained by 15.71% to $3152.0 in 2013.
• According to Business Quant data, Short term Debt over the past three periods registered $3152.0, $2724.0, and $2287.0 for Q1 2013, Q4 2012, and Q3 2012 respectively.